13 Psych Drugs in 4 Months: The Troubling Question in Lindsay Clancy’s Case | Dr. Roger McFillin

Alex Clark interviews clinical psychologist Dr Roger McFillin about the US case of Lindsay Clancy, a Massachusetts mother accused of killing her three children, and the claim that she was prescribed 13 psychiatric drugs in roughly four months before the deaths. McFillin describes the medication switching as a predictable setup for adverse reactions, withdrawal and what he calls iatrogenic harm, disputing conventional labels such as postpartum psychosis. He alleges that a postpartum outpatient programme flagged Clancy as harmed by multiple drugs, contacted a prescriber who did not return the call, and that subsequent clinicians continued prescribing SSRIs and other psychotropics.

McFillin argues that abrupt stopping of SSRIs is unsafe and says clinicians should consider pharmacogenetic testing (CYP variants) to identify slow metabolisers, linking this to akathisia and violence risk; he also dismisses reported toxicology evidence about ‘below toxic’ levels as a distraction from consciousness-altering effects. He claims expert testimony in the case repeated the ‘chemical imbalance’ explanation for depression, which he calls pharmaceutical marketing.

The discussion broadens into criticism of corporate medicine, maternity leave and social isolation, and a wider political and spiritual framing in which McFillin alleges institutional capture by pharma and other forces. Clark repeatedly urges viewers not to abruptly stop psychiatric medications and asks for practical guidance on tapering and warning signs, while McFillin reiterates a preference for non-drug approaches and building alternative care networks.

• McFillin says Clancy’s medication changes created predictable risks of adverse reactions and withdrawal, and he frames the case as iatrogenic harm rather than postpartum psychosis.
• He alleges a postpartum programme warned Clancy was harmed by multiple drugs and that the prescriber ‘never returns the call’.
• McFillin advocates slow tapering and raises pharmacogenetic testing (CYP variants) as relevant to SSRI metabolism and akathisia risk.
• He dismisses toxicology framing of ‘below toxic/therapeutic’ levels as irrelevant to drug-induced mental disturbance.
• McFillin claims court testimony repeated the ‘chemical imbalance’ theory, which he calls a marketing narrative.
• Clark links the discussion to accountability and punishment, while also arguing the medical system may have wronged Clancy.